• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

by Fred Pennic 11/18/2020 Leave a Comment

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

What You Should Know: - COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding. - Access to over one million patient data records and additional funding support enhanced real-world data and analytics services in oncology. COTA, Inc., a Boston, MA-based healthcare technology company that uses real-world data to bring clarity to cancer care, today announced it has raised $34 million in Series D funding led
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

FDA Extends RCA With COTA to Explore COVID’s Effect on Cancer

by Fred Pennic 11/04/2020 Leave a Comment

FDA Extends RCA With COTA to Explore COVID's Effect on Cancer

What You Should Know: - The FDA just extended its research collaboration agreement (RCA) with COTA, specifically looking at how COVID-19 is affecting cancer. - With this expanded agreement, COTA and the FDA will use real-world data to explore the impact of COVID-19 and the pandemic on cancer treatment, with the opportunity to expand into other oncology questions in the future. COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform

by Jasmine Pennic 08/13/2020 Leave a Comment

Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform

What You Should Know: - Mission Bio raises $70 million in Series C funding led by Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics. - Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.  Mission Bio, Inc., a South San Francisco,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

2020 MedTech Breakthrough Award Winners Announced

by Fred Pennic 05/21/2020 Leave a Comment

2020 MedTech Breakthrough Award Winners Announced

What You Should Know: - MedTech Breakthrough announces 2020 MedTech Breakthrough Award Winners that recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries today. - The 2020 MedTech Breakthrough Awards program is open to all individuals, companies, and organizations involved in producing digital health and medical technology products and services.  MedTech Breakthrough, a market intelligence organization that
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Cota Lands $40M to Accelerate Value-based Precision Medicine

by HITC Staff 02/22/2018 Leave a Comment

Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients

Cota, a NYC-based healthcare data and analytics company bridging precision medicine to population health has raised $40 million in Series C funding led by QVIA and was contributed to by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings.The funding will go towards rapidly scaling its
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Cota Partners with Miami Cancer Institute to Fuel Personalized Cancer Treatment

by Fred Pennic 01/03/2018 Leave a Comment

Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients

Cota, a healthcare data and analytics company bridging precision medicine to population health has announced their latest collaboration with Baptist Health South Florida to advance cancer treatment and clinical research at the new Miami Cancer Institute (MCI). The partnership will further support the organization’s initiative of precision medicine, improve care delivery and ensure the most effective treatment for every type of cancer.MCI will leverage Cota’s Provider Solution to identify
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Memorial Sloan Kettering, Cota Partner to Advance Personalized Cancer Treatment

by HITC Staff 11/09/2017 Leave a Comment

Memorial Sloan Kettering Cancer Center

In 2011, Cota, a healthcare data and analytics company bridging precision medicine and population health, was founded by doctors for doctors. Over the past six years, the start-up has moved beyond precision medicine as a goal to a reality, and just this past year, have secured a multi-year collaboration with Novartis towards breast cancer and recruited top thought leaders in the space, like former Deputy Chief Health Officer at IBM Watson, Dr. Andrew Norden.Today, Cota announced their latest
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Cota, Hackensack Meridian Integrates “Digital Map of Cancer” Into Epic EHR

by HITC Staff 02/03/2017 Leave a Comment

Cota, Hackensack Meridian Integrates "Digital Map of Cancer" Into Epic EHR

Hackensack Meridian Health (HMH), a New Jersey-based integrated health care system and Cota, a leading data and technology platform for value-based precision medicine has teamed up to improve clinical and cost outcomes for cancer patients.As part of the partnership, HMH will integrate Cota Nodal Addresses™ (CNAs) directly into its Epic EHR to help support decision-making by oncologists at the point of care. CNAs are generated by a unique, patented digital data classification methodology that
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Big Data Cancer Platform COTA Secures $3.7M in Funding from Insurer

by Fred Pennic 09/23/2014 Leave a Comment

Big Data Cancer Platform COTA Secures $3.7M in Funding from Insurer

Big data cancer platform COTA closes $3.7M of planned $7M Series A funding round to make value-based cancer care delivery and reimbursement a reality.  The promise of value-based care and big data insights in healthcare are undeniable. But few have found a way to integrate it in a real-life setting and obtain the consensus of payers, providers, patients, technology partners etc. COTA, which today closed $3.7M in Series A funding from Horizon Healthcare Services, Inc. , is changing that status
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |